Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
April 5, 2018
CALCALISTECH
“Boston-headquartered company FDNA Inc. developed a system that uses facial recognition to identify rare underlying genetic medical conditions which a doctor may not be able to easily detect. Like Down syndrome, many conditions manifest in a person’s face, but it is impossible for a doctor to recognize conditions that are less common just by looking at the patient.”
The article from CTech explores how FDNA, utilizing artificial intelligence technology, is revolutionizing healthcare diagnostics. FDNA’s AI system analyzes facial features, enabling early and accurate diagnosis of rare genetic disorders. By examining subtle facial cues, the technology can identify conditions that might be missed by traditional methods. This AI-driven approach promises significant advancements in personalized medicine, offering faster, non-invasive identification of health issues. The integration of AI in genetic diagnostics illustrates the potential for such technology to transform both patient experiences and outcomes in healthcare.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…